InvestorsObserver
×
News Home

What is the Market's View on Agile Therapeutics Inc (AGRX) Stock's Price and Volume Trends

Friday, December 04, 2020 11:54 AM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Agile Therapeutics Inc (AGRX) Stock's Price and Volume Trends

The market has been high on Agile Therapeutics Inc (AGRX) stock recently. AGRX gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Agile Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on AGRX!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With AGRX Stock Today?

Agile Therapeutics Inc (AGRX) stock is trading at $3.01 as of 11:44 AM on Friday, Dec 4, a gain of $0.13, or 4.34% from the previous closing price of $2.88. The stock has traded between $2.88 and $3.09 so far today. Volume today is 961,756 compared to average volume of 855,336.

To screen for more stocks like Agile Therapeutics Inc click here.

More About Agile Therapeutics Inc

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.

Click Here to get the full Stock Score Report on Agile Therapeutics Inc (AGRX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App